Macrogenics Inc. (MGNX) stock forecast and price target
Price $2.20 · data as of November 13, 2026
12-month price target
Average target$8.00
Upside / downside+263.6%
Analysts4
ConsensusBuy
Low $4.00Average $8.00High $11.00
Gold marker: average target · white marker: today’s price ($2.20)
Analyst ratings
Strong buy 1Buy 2Hold 4Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.47 | −109.3% | $104M |
| Next fiscal year ends December 31, 2027 | $-1.70 | +31.4% | $74M |
| Next quarter ends December 31, 2026 | $-0.49 | −122.7% | $15M |
| Quarter after ends March 31, 2027 | $-0.48 | +17.2% | $8M |
Consensus of the analysts covering Macrogenics, updated daily.
Frequently asked questions
What is the Macrogenics stock price target?
The average 12-month target from 4 analysts is $8.00, 263.6% above the current price of $2.20 Targets range from $4.00 to $11.00.
Is Macrogenics a buy according to analysts?
The consensus rating is “Buy” (1 strong buy, 2 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Macrogenics expected to earn?
Analysts expect EPS of $-2.47 for the fiscal year ending December 31, 2026 and $-1.70 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.